Physician
Endocrinology
Dr. Frederick R. Singer, MD
|
|
Give Review
Frederick Singer works in the field of Endocrinology. He researched medicine at University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is a top medical university. University of California San Francisco School of Medicine is ranked 3/3 in Research/PrimaryCare. He received 1 awards: "Elected Member". Frederick Singer is a published MD as well. He has 99 publications published. The latest was: Evaluation of 99mTc diphosphonate kinetics and bone scans in patients with Paget''s disease before and after calcitonin treatment. He is registered with Medicare.
Publications
- Paget's Disease of bone-genetic and environmental factors.
- Paget's Disease of Bone: An Endocrine Society Clinical Practice Guideline.
- Metabolic bone Disease: atypical femoral fractures.
- The etiology of Paget's Disease of bone: viral and genetic interactions.
- Sentinel lymph node biopsy for papillary Thyroid cancer: 12 years of experience at a single institution.
- Bone: Do all Paget Disease risk genes incriminate the osteoclast?
- Paget Disease: when to treat and when not to treat.
- Skeletal and hormonal effects of magnesium Deficiency.
- Multimarker circulating DNA assay for assessing blood of prostate Cancer patients.
- Using biochemical markers of bone turnover in clinical practice.
- Cinacalcet for the treatment of primary Hyperparathyroidism.
- Sequestosome 1 (SQSTM1) mutations in Paget's Disease of bone from the United States.
- Detection of circulating tumor cells in early-stage breast Cancer metastasis to axillary lymph nodes.
- Hypermethylation of adenosine triphosphate-binding cassette transporter genes in primary Hyperparathyroidism and its effect on sestamibi imaging.
- Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget Disease.
- Medical management of Paget's Disease of bone: indications for treatment and review of current therapies.
- Clinical and cellular phenoTypes associated with sequestosome 1 (SQSTM1) mutations.
- Ultrastructure of bone cells in Paget's Disease of bone.
- Epigenetic analysis of body fluids and tumor tissues: application of a comprehensive molecular assessment for early-stage breast Cancer patients.
- Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease.
- Weight of normal paraThyroid glands in patients with paraThyroid adenomas.
- Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies.
- Three novel mutations in SQSTM1 identified in familial Paget's Disease of bone.
- The effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast Cancer.
- Detection of tumor-specific genetic alterations in bone marrow from early-stage breast Cancer patients.
- Stanniocalcin-1: a novel molecular blood and bone marrow marker for human breast Cancer.
- Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis.
- Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's Disease.
- Vitamin-D-resistant osteomalacia in hemodialysis patients lacking secondary Hyperparathyroidism.
- Abnormal Calcium homeostasis in sarcoidosis.
- Pathogenesis of Hypercalcemia of malignancy.
- Role of the bisphosphonate etidronate in the therapy of cancer-related Hypercalcemia.
- Paget''s Disease. Reversal of severe paraparesis using calcitonin.
- Hypercalcemia and hypocalcemia.
- Measurement of paraThyroid hormone.
- Electroencephalographic abnormalities in Hypercalcemia.
- Clinical effects of 1,25-dihydroxyVitamin D3 in uremic patients with overt osteodystrophy.
- Radiographic and radionuclide imaging in multiple myeloma: the role of gallium scintigraphy: concise communication.
- Hypercalcemia in reticulum cell sarcoma without hyperparathyroidism of skeletal metastases.
- Homeostasis and action of paraThyroid hormone in normal man and patients with mild renal failure.
- Microfollicular Thyroid carcinoma with amyloid rich stroma, resembling the medullary carcinoma of the Thyroid (MCT).
- Production of 1,25-dihydroxyVitamin D3 by pulmonary alveolar macrophages from patients with sarcoidosis.
- Bisphosphonates in the treatment of disorders of mineral Metabolism.
- Gallium scanning in Paget's Disease of bone: effect of calcitonin.
- Relationship between urinary Calcium and Calcium intake during calcitriol administration.
- Pharmacokinetics and biologic effects of calcitriol in normal humans.
- 1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma paraThyroid hormone levels in uremic osteodystrophy.
- Paget's Disease of bone: pathophysiology and diagnosis.
- Use of 1,25(OH)2-vitamin D3 to separate ''Types'' on renal osteodystrophy.
- Radioimmunoassay for human paraThyroid hormone.
- Peripheral Metabolism of bovine parathyroid hormone in the dog.
- Slow-release sodium fluoride in Osteoporosis.
- Salmon calcitonin therapy for Paget's Disease of bone. The problem of acquired clinical resistance.
- Multiple osteocalcin fragments in human urine and serum as detected by a midmolecule osteocalcin radioimmunoassay.
- Isolation and structural identification of 1,25-dihydroxyVitamin D3 produced by cultured alveolar macrophages in sarcoidosis.
- Therapy of Hypercalcemia of malignancy.
- Calcitonin stimulates bone formation when administered prior to initiation of osteogenesis.
- Intestinal Calcium absorption in patients with hyperthyroidism.
- Specific internalization and action of 1,25-dihydroxyVitamin D3 in cultured dermal fibroblasts from patients with X-linked hypophosphatemia.
- Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis.
- Mithramycin treatment of intractable Hypercalcemia due to parathyroid carcinoma.
- Some acute effects of administered porcine calcitonin in man.
- Effects of long-term therapy with calcitriol in patients with moderate renal failure.
- The high incidence of persistent secondary Hyperparathyroidism after renal homotransplantation.
- Treatment of Paget''s Disease of bone.
- UCLA conference: Current concepts of bone Metabolism.
- Nonparathyroid humoral hypercalcemia in patients with neoplastic Diseases.
- ParaThyroid gland responsiveness to acute hypocalcemia in dialysis osteomalacia.
- Relationship between the kidney and paraThyroid hormone.
- A skeletal mineralizing defect in dialysis patients: a Syndrome resembling osteomalacia but unrelated to viatamin D.
- The effects of metabolic acidosis on bone formation and bone resorption in the rat.
- In vivo morphologic changes in the rat osteoclast induced by gallium nitrate: the result of toxicity or other effects?
- The spectrum of pathology in osteomalacia.
- Postpartum resolution of hypocalcemia in a lactating hypoparaThyroid patient.
- Heterogeneity of immunoreactive calcitonin in extracts of medullary Thyroid carcinoma.
- A high prevalence of hypomagnesemia and hypermagnesemia in hospitalized patients.
- Treatment of thyrotoxic Hypercalcemia with propranolol.
- Abundant expression of paraThyroid hormone-related protein in primary rat aortic smooth muscle cells accompanies serum-induced proliferation.
- Albers-Schönberg disease (autosomal dominant osteopetrosis, Type II) results from mutations in the ClCN7 chloride channel gene.
- Serum thyroid hormone indexes in patients with primary Hyperparathyroidism.
- Magnesium Deficiency in a medical ICU population.
- Cobalamin and osteoblast-specific proteins.
- Vitamin D metabolite-mediated Hypercalcemia and hypercalciuria patients with AIDS- and non-AIDS-associated lymphoma.
- Osteotomy for tibia vara in Paget''s Disease under cover of calcitonin.
- Advances in Paget's Disease treatment.
- Paget's Disease: complications and controversies.
- Preliminary trials with 24,25-dihydroxyVitamin D3 in dialysis osteomalacia.
- Immunoassay for human calcitonin. II. Clinical studies.
- Acute effects of calcitonin on bone formation in man.
- Immunochemiluminometric and immunoradiometric determinations of intact and total immunoreactive parathyrin: performance in the differential diagnosis of Hypercalcemia ...
- Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.
- Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase.
- Human calcitonin treatment of Paget''s Disease of bone.
- Characterization and assay of tartrate-resistant acid phosphatase activity in serum: potential use to assess bone resorption.
- Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared.
- A urine midmolecule osteocalcin assay shows higher discriminatory power than a serum midmolecule osteocalcin assay during short-term alendronate treatment of osteoporo...
- Paget''s Disease of bone: a slow virus infection?
- Evaluation of 99mTc diphosphonate kinetics and bone scans in patients with Paget''s Disease before and after calcitonin treatment.
Schools
University Of California San Francisco School Of Medicine
UCLA Affil Hosps
Va Hospital Wadsworth
Massachusetts General Hospital
Conditions Treated
- Adrenal Insufficiency
- Calcium Metabolism Disorders
- Cushing's Syndrome
- Diabetes Type 1
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- Elected Member
Education
-
Massachusetts General Hospital -
VA Greater Los Angeles Healthcare System -
University of California San Francisco School of Medicine
Drug Facts
| NPI NUMBER | 1083771448 | |
| NPPES Provider LastName | SINGER | |
| NPPES Provider FirstName | FREDERICK | |
| NPPES Provider ZIPCode | 904042032 | |
| NPPES Provider State | CA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 235.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1083771448 |
| Last Name Of The Provider | SINGER |
| First Name Of The Provider | FREDERICK |
| View All |
Similar Doctors
|
Dr. Joseph J. Pinzone, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linda A. Glaser, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janet Winikoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce B. Ettinger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephanie Smooke Praw, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip Barnett, MD |